- Home
- MGRX vs SBFM Comparison
MGRX vs SBFM Comparison
Compare MGRX & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRX
- SBFM
- Stock Information
- Founded
- MGRX 2021
- SBFM 2006
- Country
- MGRX United States
- SBFM United States
- Employees
- MGRX N/A
- SBFM N/A
- Industry
- MGRX Computer Software: Prepackaged Software
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- MGRX Technology
- SBFM Health Care
- Exchange
- MGRX Nasdaq
- SBFM Nasdaq
- Market Cap
- MGRX 23.3M
- SBFM 6.6M
- IPO Year
- MGRX 2023
- SBFM N/A
- Fundamental
- Price
- MGRX $2.11
- SBFM $1.47
- Analyst Decision
- MGRX
- SBFM Strong Buy
- Analyst Count
- MGRX 0
- SBFM 1
- Target Price
- MGRX N/A
- SBFM $15.00
- AVG Volume (30 Days)
- MGRX 203.5K
- SBFM 43.5K
- Earning Date
- MGRX 11-13-2025
- SBFM 11-04-2025
- Dividend Yield
- MGRX N/A
- SBFM N/A
- EPS Growth
- MGRX N/A
- SBFM N/A
- EPS
- MGRX N/A
- SBFM N/A
- Revenue
- MGRX $516,030.00
- SBFM $36,341,741.00
- Revenue This Year
- MGRX N/A
- SBFM $32.20
- Revenue Next Year
- MGRX N/A
- SBFM $32.74
- P/E Ratio
- MGRX N/A
- SBFM N/A
- Revenue Growth
- MGRX N/A
- SBFM 19.22
- 52 Week Low
- MGRX $1.32
- SBFM $1.17
- 52 Week High
- MGRX $7.66
- SBFM $3.90
- Technical
- Relative Strength Index (RSI)
- MGRX 52.73
- SBFM 51.44
- Support Level
- MGRX $2.07
- SBFM $1.45
- Resistance Level
- MGRX $2.33
- SBFM $1.53
- Average True Range (ATR)
- MGRX 0.23
- SBFM 0.06
- MACD
- MGRX -0.02
- SBFM 0.01
- Stochastic Oscillator
- MGRX 14.60
- SBFM 65.71
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.